Xilong Scientific Co., Ltd.
002584.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4,037,732 | CN¥5,985,934 | CN¥4,055,550 | CN¥6,203,294 |
| - Cash | CN¥593,214 | CN¥559,890 | CN¥691,010 | CN¥769,863 |
| + Debt | CN¥910,738 | CN¥1,009,652 | CN¥1,047,569 | CN¥694,708 |
| Enterprise Value | CN¥4,355,256 | CN¥6,435,696 | CN¥4,412,108 | CN¥6,128,140 |
| Revenue | CN¥7,816,466 | CN¥7,693,247 | CN¥6,183,209 | CN¥6,837,668 |
| % Growth | 1.6% | 24.4% | -9.6% | – |
| Gross Profit | CN¥535,522 | CN¥459,703 | CN¥441,501 | CN¥557,419 |
| % Margin | 6.9% | 6% | 7.1% | 8.2% |
| EBITDA | CN¥176,027 | CN¥153,083 | CN¥219,600 | CN¥321,996 |
| % Margin | 2.3% | 2% | 3.6% | 4.7% |
| Net Income | CN¥61,773 | CN¥33,348 | CN¥89,064 | CN¥187,064 |
| % Margin | 0.8% | 0.4% | 1.4% | 2.7% |
| EPS Diluted | 0.11 | 0.06 | 0.15 | 0.32 |
| % Growth | 83.3% | -60% | -53.1% | – |
| Operating Cash Flow | CN¥302,164 | -CN¥284,715 | -CN¥190,883 | CN¥346,618 |
| Capital Expenditures | -CN¥44,936 | -CN¥215,248 | -CN¥323,708 | -CN¥56,727 |
| Free Cash Flow | CN¥257,228 | -CN¥499,962 | -CN¥514,590 | CN¥289,891 |